Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Neuroinflammation and Neurodegeneration Mechanisms, and Functional Brain Connectivity Studies.
A head‐to‐head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic
<i>KLOTHO</i> KL‐VS heterozygosity is associated with diminished age‐related neuroinflammation, neurodegeneration, and synaptic dysfunction in older cognitively unimpaired adults
Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology
Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
Evaluation of ATN <sub>PD</sub> framework and biofluid markers to predict cognitive decline in early Parkinson’s disease
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
Inflammation, tau pathology, and synaptic integrity associated with sleep spindles and memory prior to β-amyloid positivity
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer’s continuum
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study
UCL Discovery (University College London) 2021cited by 48position: middle
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's <i>continuum</i>